Cargando…

Effective Drug Regulation : a Multicountry Study.

Drugs play a crucial role in saving lives, restoring health, and preventing diseases and epidemics. But they need to be safe, efficacious, of good quality, and used rationally. This means that their production, import/export, storage, supply and distribution should be subject to government control t...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Ratanawijitrasin, S.
Otros Autores: Wondemagegnebu, E.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Albany : World Health Organization, 2002.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Mi 4500
001 EBOOKCENTRAL_ocn935263257
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |n|||||||||
008 160123s2002 nyu o 000 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCQ  |d MERUC  |d CNNOR  |d OCLCF  |d OCLCO  |d ZCU  |d U3W  |d OCLCQ  |d OCLCO  |d ICG  |d OCLCQ  |d DKC  |d OCLCQ  |d UX1  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
020 |a 9789240680296 
020 |a 9240680292 
029 1 |a AU@  |b 000059584939 
029 1 |a DEBBG  |b BV044122638 
035 |a (OCoLC)935263257 
050 4 |a RA401.A1 ǂb R38 2002eb 
060 4 |a 2002 K-267 
060 4 |a QV 33.1  |b R232e 2002 
082 0 4 |a 362.17/82  |a 615.19 
049 |a UAMI 
100 1 |a Ratanawijitrasin, S. 
245 1 0 |a Effective Drug Regulation :  |b a Multicountry Study. 
260 |a Albany :  |b World Health Organization,  |c 2002. 
300 |a 1 online resource (150 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
505 0 |a 1. DRUG REGULATION: OBJECTIVES AND ISSUES; 1.1 Drugs as an instrument of public health; 1.2 Controlling private behaviour for public purposes; 1.3 Objectives and organization of this report; 2. MULTICOUNTRY STUDY ON EFFECTIVE DRUG REGULATION ; 2.1 Project rational and development; 2.2 Study objectives; 2.3 Method of study; 2.4 Drug regulation from a comparative perspective; 3. PROFILE OF THE COUNTRIES; 3.1 General background; 3.2 Political environment; 3.3 Pharmaceutical sector environment; 4. REGULATORY FRAMEWORK; 4.1 Missions and goals of drug regulation; 4.2 Domains of control. 
505 8 |a 4.3 Other non-regulatory pharmaceutical functions4.4 National drug policy; 4.5 Historical development of drug regulation; 5. REGULATORY CAPACITY; 5.1 Legal basis, organizational structure and authority; 5.2 Human resources; 5.3 Financing drug regulation; 5.4 Planning, monitoring and evaluating implementation; 5.5 Problems encountered and strengths identified; 5.6 Political influence and accountability; 6. LICENSING OF MANUFACTURING, DISTRIBUTION AND RETAIL SALE; 6.1 Power and process; 6.2 Human resources; 6.3 Paying for licensing; 6.4 Performance; 7. INSPECTION AND SURVEILLANCE. 
505 8 |a 7.1 Power and process: comparing structures and processes7.2 Human resources; 7.3 Paying for inspection; 7.4 Planning, process and performance; 8. PRODUCT ASSESSMENT AND REGISTRATION; 8.1 Power and process; 8.2 Human resources; 8.3 Paying for registration; 8.4 Performance; 8.5 Adverse drug reaction monitoring; 8.6 Clinical trials; 9. CONTROL OF DRUG PROMOTION AND ADVERTISING; 9.1 Power and process: comparing structures and processes; 9.2 Performance; 10. DRUG QUALITY CONTROL LABORATORY; 10.1 Power and process; 10.2 Human resources; 10.3 Paying for quality control; 10.4 Performance. 
505 8 |a 11. ASSESSING REGULATORY PERFORMANCE11.1 Assessing government functions: an essential part of policy-making; 11.2 Monitoring and evaluation system; 11.3 Monitoring and evaluating the effectiveness of drug regulation; 11.4 Monitoring and evaluating the efficiency of drug regulation; 11.5 Monitoring and evaluating the accountability and transparency of drug regulation; 11.6 Availability of information for assessment; 12. CONCLUSIONS AND RECOMMENDATIONS FOR EFFECTIVE DRUG REGULATION; 12.1 Conclusions related to regulatory structures; 12.2 Conclusions related to regulatory processes. 
500 |a 12.3 Recommendations for effective drug regulation. 
520 |a Drugs play a crucial role in saving lives, restoring health, and preventing diseases and epidemics. But they need to be safe, efficacious, of good quality, and used rationally. This means that their production, import/export, storage, supply and distribution should be subject to government control through prescribed norms and standards and an effective regulatory system. Substandard and counterfeit drugs proliferate primarily in an environment where drug regulation has proved ineffective. This publication presents a synthesis of studies on drug regulation carried out in 10 countries: Australia. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Drugs  |x Law and legislation. 
650 0 |a Pharmaceutical policy. 
650 6 |a Médicaments  |x Politique gouvernementale. 
650 7 |a Drugs  |x Law and legislation  |2 fast 
650 7 |a Pharmaceutical policy  |2 fast 
700 1 |a Wondemagegnebu, E. 
758 |i has work:  |a Effective drug regulation (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCYGGw6Pp9Ym4MBCJ8qpRqP  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Ratanawijitrasin, S.  |t Effective Drug Regulation : A Multicountry Study.  |d Albany : World Health Organization, ©2002  |z 9789241562065 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=284592  |z Texto completo 
938 |a EBL - Ebook Library  |b EBLB  |n EBL284592 
994 |a 92  |b IZTAP